Exclusive

Publication

Byline

US Patent Issued to Virginia Commonwealth University on June 2 for "Bivalent ligands to understand dimerization of the mu opioid receptor and the chemokine receptor CCR5 in neurological disorders" (Virginia Inventor)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,643,909, issued on June 2, was assigned to Virginia Commonwealth University (Richmond, Va.). "Bivalent ligands to understand dimerization of the... Read More


US Patent Issued to SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE on June 2 for "Substituted pyrazolo[3,4-bpyridines as ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) modulators" (Japanese, American Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,643,910, issued on June 2, was assigned to SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE (La Jolla, Calif.). "Substituted pyrazolo[3,4-bpyr... Read More


US Patent Issued to SCINOPHARM TAIWAN on June 2 for "Process for preparing Relugolix and intermediates thereof" (Taiwanese Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,643,911, issued on June 2, was assigned to SCINOPHARM TAIWAN LTD. (Tainan, Taiwan). "Process for preparing Relugolix and intermediates thereof" ... Read More


US Patent Issued to LES LABORATOIRES SERVIER on June 2 for "Macrocyclic compounds, a process for their preparation and pharmaceutical compositions containing them" (Hungarian, French, German Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,643,912, issued on June 2, was assigned to LES LABORATOIRES SERVIER (Suresnes Cedex, France). "Macrocyclic compounds, a process for their prepar... Read More


US Patent Issued to Amgen on June 2 for "Mcl-1 inhibitor formulations" (California, Massachusetts Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,643,913, issued on June 2, was assigned to Amgen Inc. (Thousand Oaks, Calif.). "Mcl-1 inhibitor formulations" was invented by James E. Huckle (M... Read More


US Patent Issued to Samsung Display on June 2 for "Organic molecules for optoelectronic devices" (German Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,643,914, issued on June 2, was assigned to Samsung Display Co. Ltd. (Yongin-si, South Korea). "Organic molecules for optoelectronic devices" was... Read More


US Patent Issued to Dow Global Technologies on June 2 for "Olefin polymerization catalysts bearing a 6-amino-N-aryl azaindole ligand" (Michigan, Connecticut, Indiana Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,643,915, issued on June 2, was assigned to Dow Global Technologies LLC (Midland, Mich.). "Olefin polymerization catalysts bearing a 6-amino-N-ar... Read More


US Patent Issued to Brentano Biotechnology Associates on June 2 for "Probe related reagents and methods" (California Inventor)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,643,916, issued on June 2, was assigned to Brentano Biotechnology Associates (San Jose, Calif.). "Probe related reagents and methods" was invent... Read More


US Patent Issued to Compass Pathfinder on June 2 for "Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use" (British, American Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,643,917, issued on June 2, was assigned to Compass Pathfinder Ltd. (Altrincham, Great Britain). "Preparation of psilocybin, different polymorphi... Read More


US Patent Issued to Betagenon on June 2 for "Thiadiazolone derivatives and their use as AMPK agonists for the treatment of diabetes and related disorders" (Swedish Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,643,918, issued on June 2, was assigned to Betagenon AB (Umea, Sweden). "Thiadiazolone derivatives and their use as AMPK agonists for the treatm... Read More